<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="632">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 27, 2015</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02503878</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00037965</org_study_id>
    <nct_id>NCT02503878</nct_id>
  </id_info>
  <brief_title>Sedline 4 Channel Electroencephalogram (EEG) Monitoring During Suppression of Unilateral Hemispheric Function (Wada Test</brief_title>
  <official_title>Sedline 4 Channel Electroencephalogram (EEG) Monitoring During Suppression of Unilateral Hemispheric Function (Wada Test)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of South Carolina</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of South Carolina</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Masimo Sedline brain function monitors are sensors (stickers) placed on a the forehead to
      monitor levels of &quot;sedation&quot; based on a bilateral 4-channel electroencephalogram (EEG). The
      purpose of this study is to observe the effectiveness of the Sedline monitor to detect the
      unilateral hemispheric EEG changes seen in Wada testing
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2014</start_date>
  <completion_date type="Anticipated">November 2016</completion_date>
  <primary_completion_date type="Anticipated">November 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Masimo Sedline brain function monitor- based on a bilateral 4-channel electroencephalogram (EEG). The purpose of this study is to observe the effectiveness of the Sedline monitor to detect the unilateral hemispheric EEG changes seen in Wada testing</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Seizure</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Masimo Sedline brain function monitors</intervention_name>
    <description>Masimo Sedline brain function monitors are sensors (stickers) placed on a the forehead to monitor levels of &quot;sedation&quot; based on a bilateral 4-channel electroencephalogram (EEG). The purpose of this study is to observe the effectiveness of the Sedline monitor to detect the unilateral hemispheric EEG changes seen in Wada testing</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Participants will be 10 adult patients over 18 years old scheduled for Wada Testing at
        MUSC. One of the study team members will inform patients scheduled to undergo surgery
        about the opportunity to participate in the study prior to surgery. Patients will review
        and sign a written informed consent with a research study team member.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        18 years of age or older

        scheduled for Wada testing at MUSC

        Exclusion Criteria:

        No exclusions
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>william hand, md</last_name>
    <phone>8437925699</phone>
    <email>handw@musc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Wanda Jones, rn</last_name>
    <phone>8437921869</phone>
    <email>joneswr@musc.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>William Hand, MD</last_name>
      <phone>843-792-5699</phone>
      <email>handw@musc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Wanda Jones, rn</last_name>
      <phone>8437921869</phone>
      <email>joneswr@musc.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2015</verification_date>
  <lastchanged_date>July 17, 2015</lastchanged_date>
  <firstreceived_date>July 17, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of South Carolina</investigator_affiliation>
    <investigator_full_name>William Hand</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
